Study of Molecular Interactions of CCM Proteins by Using a GAL4-Based Yeast Two-Hybrid Screening.


Journal

Methods in molecular biology (Clifton, N.J.)
ISSN: 1940-6029
Titre abrégé: Methods Mol Biol
Pays: United States
ID NLM: 9214969

Informations de publication

Date de publication:
2020
Historique:
entrez: 12 6 2020
pubmed: 12 6 2020
medline: 13 3 2021
Statut: ppublish

Résumé

The yeast two-hybrid system was originally designed to detect protein-protein interactions using yeast transcriptional activators. Since its original description, this technique has been extensively used to identify protein-protein interactions from many different organisms, thus providing a convenient mean to both screen for proteins that interact with a protein of interest and to characterize the known interaction between two proteins. Nowadays, the yeast two-hybrid screen remains one of the leading molecular tools to study protein-protein interactions in native intracellular conditions. In these years, the technique has improved to overcome the limitations of the original assay, and many efforts have been made to scale up the technique and to adapt it to large-scale studies. In addition, variations have been introduced to enlarge the range of proteins and interactors that can be assayed by hybrid-based approaches.Several groups studying molecular mechanisms underlying the Cerebral Cavernous Malformation disease have successfully used the yeast two-hybrid system or related methods to isolate, identify, and characterize molecular interactions involved in the onset and progression of the pathology.Here we describe general principles, strengths, and limits of the yeast two-hybrid technology, and the basic protocol for a yeast two-hybrid library screening and for a small-scale yeast two-hybrid assay by using a GAL4-based system.

Identifiants

pubmed: 32524564
doi: 10.1007/978-1-0716-0640-7_25
doi:

Substances chimiques

Biomarkers 0
Peptide Library 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

345-369

Auteurs

Federica Finetti (F)

Department of Biotechnology, Chemistry and Pharmacy, University of Siena, Siena, Italy.
CCM Italia Research Network, Torino, Italy.

Lorenza Trabalzini (L)

Department of Biotechnology, Chemistry and Pharmacy, University of Siena, Siena, Italy. lorenza.trabalzini@unisi.it.
CCM Italia Research Network, Torino, Italy. lorenza.trabalzini@unisi.it.

Articles similaires

C-Reactive Protein Humans Biomarkers Inflammation
Humans Retrospective Studies Male Critical Illness Female
Respiratory Syncytial Virus Infections Humans Animals Mice STAT3 Transcription Factor
Humans Male Female Intensive Care Units COVID-19

Classifications MeSH